GENERAL ATLANTIC, L.P. Q4 2024 Filing
Filed February 7, 2025
Portfolio Value
$2.8T
Holdings
16
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (16 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DLODLOCAL | 63,906,695 | $719.6B | 25.61% | |
| 2 | ALHCALIGNMENT HEALTHCARE | 60,993,323 | $686.2B | 24.43% | |
| 3 | ALKTALKAMI | 9,645,318 | $353.8B | 12.59% | |
| 4 | XPXP, INC | 29,617,733 | $351.0B | 12.49% | |
| 5 | CNTACENTESSA PHARMACEUTICALS | 9,681,818 | $162.2B | 5.77% | |
| 6 | AKROAKERO THERAPEUTICS | 5,233,989 | $145.6B | 5.18% | |
| 7 | PHVSPHARVARIS | 7,531,252 | $144.4B | 5.14% | |
| 8 | EWCZEUROPEAN WAX CENTER | 13,110,492 | $87.4B | 3.11% | |
| 9 | RPRXROYALTY PHARMA | 1,500,000 | $38.3B | 1.36% | |
| 10 | IMCRIMMUNOCORE | 1,261,684 | $37.2B | 1.32% | |
| 11 | THRDTHIRD HARMONIC BIO | 3,372,323 | $34.7B | 1.24% | |
| 12 | RSKDRISKIFIED | 5,324,998 | $25.2B | 0.90% | |
| 13 | SLRNACELYRIN | 2,695,327 | $8.5B | 0.30% | |
| 14 | ADAGADAGENE | 3,825,952 | $7.6B | 0.27% | |
| 15 | 5ZZ0WISH | 609,616 | $4.3B | 0.15% | |
| 16 | GROVGROVE COLLABORATIVE | 2,474,859 | $3.4B | 0.12% |